Columbia Care Becomes First Company To Produce Vape Extract Products In The UK

Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) announced Tuesday that it is the first company to formulate extract vaporizer pen products on UK-based manufacturing premises that are licensed and approved by the Medicines and Healthcare products Regulatory Agency (MHRA) and Home Office of the United Kingdom.

The products launched under its flagship medical Ceed brand and are comprised of four formulations that will be available to throughout the UK when prescribed by a specialist consultant. These new vaporizer pens complete Columbia Care’s initial medical product portfolio, which includes tinctures, launched in April 2020, and its proprietary solid-fill powder capsules, launched in April 2021, that remain unique in the UK market.

“Columbia …

Full story available on Benzinga.com

More Columbia Care Becomes First Company To Produce Vape Extract Products In The UK